JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...
Essentially, the non-inferiority margin is the maximum clinically acceptable extent to which the new drug can be less effective than the existing one. Typically, in diabetes trials, the US Food and ...
Non-inferiority trials have become an essential instrument in clinical research, particularly when the goal is to demonstrate that an experimental treatment is not unacceptably worse than an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results